Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Little is known about snakebites by Naja samarensis, a species unique to the Philippines. The aim here is to describe the clinical and epidemiological characteristics of patients bitten by this medically important cobra in the Eastern Visayas.

Methods: A hospital-based prospective study analysed the features of snakebite patients attending Eastern Visayas Medical Center between June 2022 and May 2023. Logistic regression analysis identified the factors associated with severity.

Results: A total of 175 snakebite patients with five fatalities were included. Naja samarensis was most commonly implicated (n=49, 28.0%), although it could be definitively identified, by examining photographs of the snake responsible, in only four cases. The N. samarensis bites occurred in grass or rice fields, in daytime, and during farming activities, but the people bitten were most frequently students (34.7%) who were bitten at home (36.7%). Patients bitten by N. samarensis often presented with cytotoxic (63.3%) and neurotoxic signs (46.9%). Traditional remedies were common, resulting in delayed presentation to the hospital. Bites by N. samarensis, and older age (>44 y) were independently associated with severity (adjusted OR of 10.33 and 7.89, respectively).

Conclusion: Naja samarensis is a major cause of severe snakebites in this region. Pre-hospital treatment frequently involves wasted time and unproven traditional methods. Enhancement of public awareness is urgently needed. Development of a diagnostic test for species identification is warranted to improve future surveys and management.

Download full-text PDF

Source
http://dx.doi.org/10.1093/trstmh/trae110DOI Listing

Publication Analysis

Top Keywords

naja samarensis
16
snakebite patients
12
patients bitten
8
samarensis
7
patients
5
characteristics snakebite
4
naja
4
patients naja
4
samarensis philippines
4
philippines prospective
4

Similar Publications

Venom ophthalmia from a spitting Samar cobra (Naja samarensis): A case of corneal injury.

Toxicon

July 2025

Coordination Office for Emergency Medicine and International Response, Acute and Critical Care Center, Nagasaki University Hospital, Nagasaki, Japan; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.

Snake venom ophthalmia is a potentially blinding condition requiring prompt management. This case presents the first detailed ophthalmologic examination of Samar cobra (Naja samarensis) venom ophthalmia, an endemic Philippine species. A 47-year-old Filipino male reported immediate burning sensation and eye irritation after being spat on while clearing debris under his home.

View Article and Find Full Text PDF

Background: Little is known about snakebites by Naja samarensis, a species unique to the Philippines. The aim here is to describe the clinical and epidemiological characteristics of patients bitten by this medically important cobra in the Eastern Visayas.

Methods: A hospital-based prospective study analysed the features of snakebite patients attending Eastern Visayas Medical Center between June 2022 and May 2023.

View Article and Find Full Text PDF
Article Synopsis
  • The study addresses the lack of observational research on neurotoxic snakebites in the Philippines, focusing on treatment with Purified Cobra Antivenom (PCAV).
  • A chart review was conducted on snakebite patients treated with PCAV at the Eastern Visayas Medical Center from 2016 to 2020, revealing patient demographics, dosage received, and hospital stay duration.
  • Results showed that most patients were young males from rural areas, with a notable proportion requiring higher doses of PCAV linked to longer hospital stays; the study suggests further research to optimize treatment strategies.
View Article and Find Full Text PDF

Inhibition of bacterial biofilms by the snake venom proteome.

Biotechnol Rep (Amst)

September 2023

Pathogenic Mechanisms Research Group, School of Natural Sciences, University of Galway, Ireland.

Snake venoms possess a range of pharmacological and toxicological activities. Here we evaluated the antibacterial and anti-biofilm activity against methicillin-susceptible and methicillin-resistant (MSSA and MRSA) of venoms from the Samar spitting cobra and the Puff adder Both venoms prevented biofilm production by pathogenic in a growth-independent manner, with the venom being most potent. Fractionation showed the active molecule to be heat-labile and >10 kDa in size.

View Article and Find Full Text PDF